Literature DB >> 26729805

Dendritic Cell Migration and Antigen Presentation Are Coordinated by the Opposing Functions of the Tetraspanins CD82 and CD37.

Eleanor L Jones1, Janet L Wee2, Maria C Demaria1, Jessica Blakeley1, Po Ki Ho1, Javier Vega-Ramos3, Jose A Villadangos4, Annemiek B van Spriel5, Michael J Hickey6, Günther J Hämmerling7, Mark D Wright8.   

Abstract

This study supports a new concept where the opposing functions of the tetraspanins CD37 and CD82 may coordinate changes in migration and Ag presentation during dendritic cell (DC) activation. We have previously published that CD37 is downregulated upon monocyte-derived DC activation, promotes migration of both skin and bone marrow-derived dendritic cells (BMDCs), and restrains Ag presentation in splenic and BMDCs. In this article, we show that CD82, the closest phylogenetic relative to CD37, appears to have opposing functions. CD82 is upregulated upon activation of BMDCs and monocyte-derived DCs, restrains migration of skin and BMDCs, supports MHC class II maturation, and promotes stable interactions between T cells and splenic DCs or BMDCs. The underlying mechanism involves the rearrangement of the cytoskeleton via a differential activation of small GTPases. Both CD37(-/-) and CD82(-/-) BMDCs lack cellular projections, but where CD37(-/-) BMDCs spread poorly on fibronectin, CD82(-/-) BMDCs are large and spread to a greater extent than wild-type BMDCs. At the molecular level, CD82 is a negative regulator of RhoA, whereas CD37 promotes activation of Rac-1; both tetraspanins negatively regulate Cdc42. Thus, this study identifies a key aspect of DC biology: an unactivated BMDC is CD37(hi)CD82(lo), resulting in a highly motile cell with a limited ability to activate naive T cells. By contrast, a late activated BMDC is CD37(lo)CD82(hi), and thus has modified its migratory, cytoskeletal, and Ag presentation machinery to become a cell superbly adapted to activating naive T cells.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26729805     DOI: 10.4049/jimmunol.1500357

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Dendritic cell migration in health and disease.

Authors:  Tim Worbs; Swantje I Hammerschmidt; Reinhold Förster
Journal:  Nat Rev Immunol       Date:  2016-11-28       Impact factor: 53.106

2.  Tetraspanin CD82 restrains phagocyte migration but supports macrophage activation.

Authors:  Erin N S McGowan; Osanna Wong; Eleanor Jones; Julie Nguyen; Janet Wee; Maria C Demaria; Devy Deliyanti; Chad J Johnson; Michael J Hickey; Malcolm J McConville; Jennifer L Wilkinson-Berka; Mark D Wright; Katrina J Binger
Journal:  iScience       Date:  2022-06-03

3.  CD82 controls CpG-dependent TLR9 signaling.

Authors:  Nida S Khan; Daniel P Lukason; Marianela Feliu; Rebecca A Ward; Allison K Lord; Jennifer L Reedy; Zaida G Ramirez-Ortiz; Jenny M Tam; Pia V Kasperkovitz; Paige E Negoro; Tammy D Vyas; Shuying Xu; Melanie M Brinkmann; Mridu Acharaya; Katerina Artavanis-Tsakonas; Eva-Maria Frickel; Christine E Becker; Zeina Dagher; You-Me Kim; Eicke Latz; Hidde L Ploegh; Michael K Mansour; Cindy K Miranti; Stuart M Levitz; Jatin M Vyas
Journal:  FASEB J       Date:  2019-08-13       Impact factor: 5.191

4.  CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.

Authors:  Vera Rocha-Perugini; Gloria Martínez Del Hoyo; José María González-Granado; Marta Ramírez-Huesca; Virginia Zorita; Eric Rubinstein; Claude Boucheix; Francisco Sánchez-Madrid
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

5.  Caveolin-1 Expression Increases upon Maturation in Dendritic Cells and Promotes Their Migration to Lymph Nodes Thereby Favoring the Induction of CD8+ T Cell Responses.

Authors:  Cesar Oyarce; Sebastián Cruz-Gomez; Felipe Galvez-Cancino; Pablo Vargas; Hélène D Moreau; Natalia Diaz-Valdivia; Jorge Diaz; Flavio Andres Salazar-Onfray; Rodrigo Pacheco; Ana Maria Lennon-Dumenil; Andrew F G Quest; Alvaro Lladser
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

6.  Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.

Authors:  Kelly Pedrozo Ferreira; Bruna Cristine de Almeida; Laura Gonzalez Dos Anjos; Glauco Baiocchi; Fernando Augusto Soares; Rafael Malagoli Rocha; Edmund Chada Baracat; Andrey Senos Dobroff; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

7.  Differential expression of tetraspanin superfamily members in dendritic cell subsets.

Authors:  Malou Zuidscherwoude; Kuntal Worah; Alie van der Schaaf; Sonja I Buschow; Annemiek B van Spriel
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

Review 8.  Tetraspanins as Organizers of Antigen-Presenting Cell Function.

Authors:  Maria Laura Saiz; Vera Rocha-Perugini; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

Review 9.  Antitumor Immunity Is Controlled by Tetraspanin Proteins.

Authors:  Fleur Schaper; Annemiek B van Spriel
Journal:  Front Immunol       Date:  2018-05-29       Impact factor: 7.561

Review 10.  The Many and Varied Roles of Tetraspanins in Immune Cell Recruitment and Migration.

Authors:  Louisa Yeung; Michael J Hickey; Mark D Wright
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.